The future is bright; its colours, sights and sounds more vibrant and steeped in a better understanding of our consciousness and its brought to you by the wonders of psychedelic science. It is a field of study with a storied history that is experiencing a renascence as countries around the world and their governments begin to open their minds.
For those who have experienced the wonders of psychedelics, the benefits they can offer are clear. Its easy to explain that elated sense of being and self to someone who is already an enthusiast, but for the rest of the world science is the key. That is why researchers in this field want to bring science and psychedelics together, as they once were, and in the past several years they have done just that.
Within the US the Multidisciplinary Association of Psychedelic Studies (MAPS) is on the verge of receiving FDA approval of its MDMA-assisted therapy for patients with PTSD.
A year ago MAPS wrapped up six trails conducted in the US, Israel, Switzerland and Canada in which treatment resistant PTSD was treated with MDMA inspired therapy.
Its proven to be an immensely effective form of treatment which is on track for wide-scale approval by 2021. The latest study, which included 107 participants, found that 66 percent of patients no longer qualified for PTSD after just two sessions. In their previousstudy that number was 83 percent.
The success of these trials has launched MAPS into the final phase of FDA approval in which they will continue their clinical trials as well as provide training for up to 100 therapists to be certified in administering MDMA-assisted therapy.
Brad Burge, Director of Strategic Communications for MAPS, insists that the FDA and even the DEA have been extremely cooperative with their studies. Hes seen a great reception for these alternative therapies from the scientific community and their patients and expects greater acceptance as the studies continue.
I think that the momentum is strong enough and the need for alternatives is great enough that any sort of counter marketing that big pharmaceuticals would do would probably only make what were doing more popular. Says Burge.
As with anything, there are also potential risks, but Burge notes that a large part of the governments acceptance of their studies has come from the careful procedures and practices theyve adopted. Safe storage, in house administration of drugs and most of all an openness in communication with the patient.
As far as any sort of addictive potential, Brad says, there is zero evidence that a couple of administrations of MDMA in a therapeutic setting will lead to any form of dependence.
Of the 107 patients that have been treated by MAPS, only a couple have sought out the substance outside of their scheduled therapies, those patients were compelled by the results MDMA provided yet they later admitted as Burge also insists that the therapy is a crucial element.
As a result of such studies, MDMA is likely to go the way of marijuana, in that its medicinal usefulness will eventually lead to widespread acceptance.
But one psychedelic which still has a long way to go in quelling the public stigma is ironically one which could also do a lot to ease peoples fears: LSD. Widely unknown to the public, the experience of LSD is often thought of as a hallucination-inducing brain-melter. Even film portrayals of acid trips have had a difficult time capturing the true experience.
Among those who have taken the substance, it is often thought to have a positive transformational effect in their lives, especially when as with MDMA it is administered properly and in a comfortable environment. Yet the difficulty in conveying the experience has made LSD one of the most feared drugs in the world.
Much of that fear has to do with a lack of information, and short inviting the whole world to experience it for themselves in the style of Timothy Leary, rigorous scientific study is the next best way to lift that veil.
Thats where the Beckley Foundation of the UK comes in. Their organization, which aims to bring science back into the world of psychedelics, is helping us all gain a better understanding of both the substance and our own consciousness.
When we last spoke with Amanda Feilding, co-director and founder of Beckley, they had been testing the effects of psilocybin on depression with incredible results. Now she says her focus is mainlyon LSD.
Poor LSD is still not acceptable, Feilding says with a sense of despair in her voice that only someone who truly understands the substance could convey, theres still a terrible taboo on those letters.
Having lived in the world of psychedelics since their heyday Amanda has seen the effect in science, medicine and the counterculture of the 60s. She has also seen a decades long misinformation campaign which has stigmatized recreational users and the years of scientific research with them.
In the 1950s and 60s, more than 3000 research papers were published on the effects of LSD. Among these early researchers was Ronnie Sandison, whose work at Powick Hospital for the mentally ill had become recognized around the world as a breakthrough in the treatment of mental illness until LSDs association with recreational users forced the compound into obscurity.
Even the founder of Alcoholics Anonymous, Bill Wilson lauded LSD as an aid in curing alcoholism a possible use which the Beckley foundation is also looking into. Wilson who famously believed that alcoholics required a spiritual awakening in order to overcome their addiction also believed that LSD could hold the key to that awakening.
Since its founding in 1998, the Beckley Foundation has sought to revive this field of study in the name of the public good it could do. With the use of modern scientific methods and brain imaging technologies Amanda and her team can now bring scientific backing to the experiences that underground users have known for years.
In 2016, the Beckley/Imperial Research Programme produced the first images of the brain on LSD. The study was conducted on 20 volunteers, whose brains were scanned using fMRI and magnetoencephalography (MEG) after receiving either 75 micrograms of LSD or placebo.
The images, published in Proceedings of the National Academy of Sciences, displayed a luminous picture of the brain in which the Default Mode Network (DMN) had been dissolved. In other words, the rigid wiring of the brain had been freed up to enable greater connectivity. This explains the increased creativity that users experience, but it also allows for therapy to be more effective.
It shakes the rigidity of the setting, Amada explains, Mental and psychological disorder like depression, addiction, PTSD are set on hyperactivity in parts of the Default Mode Network, which is like the ego, its set into a rigid and negative setting.
For recreational users, the images provided an visual representation of the illusive ego death. Its something of a mythologized holy grail of psychedelics or a state of nirvana that is now better understood by looking at the way in which LSD affects the brain.
Ego death or ego disintegration is really the same as the flip side of the expression of the mystical experience. Amada says, The ego is basically the control mechanism to keep the status quo as it is, when that diminishes in its activity there is a flood of other activity which is rather like when the cat is away the mice will play.
That level of free-form thought can be quite overwhelming, especially when the average trip could take up to8-10 hours. This is why Amanda emphasizes that the proper setting and in the case of Beckleys studies a therapeutic guide is important to ensure a positive experience. She also believes that maintaining a regular blood glucose level is an effective way to maintain clarity and stave off a bad trip. Its one theory she aims to test in upcoming studies.
Among itss newest ventures, the Beckley/Imperial Research Programme will undergo the worlds first microdosing study to investigate reports that minor doses of around 15 micrograms increase productivity while still allowing the user to function normally. The study will have volunteers playthe ancient Chinese strategy game of Go, with one player having taken a microdose and the other a placebo, to investigate whether small doses of LSD can enhance intuitive pattern recognition and creativity. All of which is to increase our understanding of LSD, rather than base our knowledge on years of misinformation.
As a once recreational user Amanda is aware of the stigma that can affect its widespread acceptance, but also believes that there are immense benefits in bringing it out of the dark.
I think LSD has gone through a great black tunnel of publicity. Shesays, In many ways I think one can say that its the most adaptable and positive of all the drugs because what it does is expand the inner person.
For her, Beckleys work is about a much more than having a way to legally access a drug again. Its a social duty if you like, its much easier to just take LSD when youre not having to change the world.
In fact, LSD is quite available already and even relatively inexpensive on the black market, but the point of psychedelic science is education rather than access. Understanding these feared substances and the way they affect the body can ultimately help us to provide the safest possible methods of using them. Whether it be recreational of medicinal, more information is always better than propaganda, but wherever the future of psychedelics leads, its sure to be a more enlightened place.
To support the research of MAPS and the Beckley Foundation visit the links below:
See original here:
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019
- A Magic Mushroom Test Case, and the Man Behind It - OZY - November 30th, 2019
- The Two Black Women Helping To Reclaim & Encourage Natural Psychedelics Use In Oakland - Okayplayer - November 2nd, 2019
- Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain - Decrypt - November 2nd, 2019
- On writing: What illuminates a story? - Big Think - November 2nd, 2019
- The future of psychedelic science - Varsity - October 20th, 2019
- Psychedelic Drugs: Researchers experimenting with active agent in magic mushrooms to treat addiction, depression and anxiety - 60 Minutes - CBS News - October 17th, 2019
- Investors hope psychedelics are the new cannabis. Are they high? - The Economist - October 17th, 2019
- Mind Trip: Psychedelics Fighting Depression, Anxiety, Addiction - The National Herald - October 17th, 2019
- Devon Welsh on Growing a Mustache, Psychedelics, and Other Complicated Things - Interview - October 17th, 2019
- Roland Griffiths: 5 Fast Facts You Need to Know - Heavy.com - October 17th, 2019
- How Mushrooms Became Magic - The Atlantic - August 25th, 2017
- Using Mushrooms and LSD to Enhance Creativity - How to Use ... - August 20th, 2017
- LSD - Psychedelics - August 16th, 2017
- This Philosopher Thinks Psychedelic Drugs Lead to the Truth of Experience - Big Think - August 16th, 2017
- Can Psychedelics Treat Bipolar Disorder? - August 13th, 2017
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz - August 13th, 2017
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk - August 8th, 2017
- Daniel Greig, Canadian Drug Policy, Responsibilities, and Psychedelics - The Good Men Project (blog) - August 6th, 2017
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine - August 5th, 2017
- Gonzo Nieto, Drug Policy, Medical and Psychological Effects - The Good Men Project (blog) - August 3rd, 2017
- For children, it's beyond psychedelics - The Hans India - The Hans India - August 1st, 2017
- Expanding consciousness - 48 Hills - August 1st, 2017
- What Has Awe Done for Me Lately? - HuffPost - July 31st, 2017
- New book about psychedelics and weird human experiences - Boing Boing - July 26th, 2017
- Psychedelics and Normality - HuffPost - July 26th, 2017
- Reasons to Consider Trying Psychedelics - FoxWeekly - July 25th, 2017
- Psychedelic Shine takes a trip to the skies in Boulder - Boulder Daily Camera - July 22nd, 2017
- Psychedelic drugs could tackle depression in a way that antidepressants can't - INSIDER - July 22nd, 2017
- Do You Take Drugs at Festivals? This Initiative is Working on Keeping You Safe - PoliticalCritique.org - July 20th, 2017
- Should We Reclassify Marijuana as a Hallucinogen? - Big Think - July 20th, 2017
- Countdown To (Legalized) Ecstasy! Rick Doblin, MAPS, & the Psychedelic Renaissance [Podcast] - Reason (blog) - July 20th, 2017
- Can Psychedelics Be Therapy? Allow Research to Find Out - New York Times - July 18th, 2017
- Psychiatrists Say Cannabis Medicine Has Psychedelic Properties - The Marijuana Times - July 15th, 2017
- Are psychedelics the new medical marijuana? - WTSP 10 News - July 13th, 2017
- Alameda author's new book examines psychedelic drugs' medical use - East Bay Times - July 12th, 2017
- Do Psychedelic Drugs Cause the 'Prophetic Effect'? - Breaking Israel ... - Breaking Israel News - July 11th, 2017
- Shrooms Could Be Legalized Sooner Than You Think - VICE - July 11th, 2017
- Parliament George and the Psychedelics? Mayor gets playful lesson on hipness - The Telegraph (blog) - July 8th, 2017
- About Us | Trusted News Source for Psychedelic Research ... - July 7th, 2017
- My grandfather was a death row doctor. He tested psychedelic drugs on Texas inmates. - Texas Tribune - July 5th, 2017
- Psychedelics Could Help Asia's Mental Health Care, But Stigma Remains Roadblock - TheFix.com - July 4th, 2017
- Is LSD the new coffee? - FactorDaily - July 4th, 2017
- Tune in, Turn on, Stay in School - Study Breaks - July 2nd, 2017
- The brain on DMT: mapping the psychedelic drug's effects - Wired.co.uk - July 2nd, 2017
- Cannabist Show: He's psychedelic comedian Shane Mauss - The Cannabist - July 1st, 2017
- The war on drugs is back. Will psychedelic drug research survive? - The Verge - June 29th, 2017
- Psychedelics and Virtual Reality Make a Trendy but Illegal Therapy - Inverse - June 27th, 2017
- Director Ana Lily Amirpour on Cannibalism, Psychedelics, and 'Horrifying' Racism Allegations - Jezebel - June 24th, 2017